Exogenus Therapeutics

Promoting development and commercialization of extracellular vesicles and other nanoparticles to tackle major healthcare challenges

Exogenus Therapeutics Chooses Lonza to Develop a GMP-Compliant Process to Manufacture Exo-101, its Lead Exosome-Based Candidate

Collaborative R&D

Unlock Innovation Through Collaborative R&D

Together, we can accelerate development, share expertise, and create the technologies of the future.

Pipeline

Explore the progress of our innovations, from discovery to clinical development

Our Team

Get to Know the Faces behind Exogenus Therapeutics

IP & Publications

Science First!

We believe that impactful discoveries should be open and transparent.

latest news

CENTRO-01-02B7-FEDER-070018

Co-financed by:

Co-Financed-projetcs